ZSKY
Latest round
- Series A
Last raised
- Nov 2020
Total raised
- Undisclosed
Investors
- 5
About ZSKY
Established in 2018 and based in Beijing, China, ZSKY is a medical company that focuses on the research and development of individualized dendritic cell tumor vaccines (DC tumor vaccines). It cooperated with Meiteni, NEC-OI, and other enterprises. ZSKY's business is the research, development, and production of the new generation of individualized DC tumor vaccines. It built an AI-based tumor neoantigen prediction system and functional validation system for the identification of tumor neoantigens. The company's products currently undergoing clinical trials include DC vaccines for middle and advanced malignant brain tumors, intestinal cancer, liver cancer, bile duct cancer, and pancreatic cancer.
Who invested in ZSKY
5 investors across 2 rounds
See all investors in ZSKY
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ZSKY
Who invested in ZSKY?
ZSKY has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ZSKY raised?
ZSKY has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ZSKY last raise money?
ZSKY's most recent round on record is a Series A, in Nov 2020.
What does ZSKY do?
Established in 2018 and based in Beijing, China, ZSKY is a medical company that focuses on the research and development of individualized dendritic cell tumor vaccines (DC tumor vaccines).
Where is ZSKY headquartered?
ZSKY is headquartered in Beijing, China.
Which VCs invest in companies like ZSKY?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare specialists companies at ZSKY's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series A
Raising like ZSKY? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.